Novo says Wegovy injection reduced BMI and obesity rates among children in trial
Novo Nordisk says a trial found that Wegovy reduced body mass index and obesity rates in children; the drug is approved for children aged 12 and older, while no medications are currently approved for obesity treatment in children under 12.Novo Nordisk said a trial found that Wegovy injections lowered body mass index and obesity rates among children. Wegovy is already approved to treat obesity in children aged 12 and older. The supplied report says there are currently no approved medications for children under 12, but does not provide further details about the trial or its results.
cnbc.com (English) ↗+ Save